HTong Biotech, based in Shanghai, China, is a well-funded privately held start-up biotechnology company dedicated to developing biopharmaceutical products. The Company’s lead drug is a fusion protein being developed as therapeutic agents to treat a variety of diseases including neovascular ocular diseases and cancers.
